Decline of immune humoral response after BNT162b2 vaccine - 08/04/22
Highlights |
• | There is the need to better understand the humoral immunity response to mRNA vaccines against SARS-CoV-2 in a real world setting. |
• | In response to BNT162b2 we observed that at peak immunity anti-SP IgG titer range was wide, spanning more than two orders of magnitude. |
• | Anti-spike IgG declined over time to reach a residual value of about 18% at 28 weeks. |
• | Our results support the use of booster doses. |
Abbreviations : SP, SARS-CoV-2, Covid-19
Vol 84 - N° 4
P. e34-e35 - avril 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?